Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01187810
Title Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHL
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors South Plains Oncology Consortium
Indications

acute lymphoblastic leukemia

acute myeloid leukemia

non-Hodgkin lymphoma

Therapies

Fenretinide

Cytarabine

Methotrexate

Age Groups: child
Covered Countries USA


No variant requirements are available.